Company Filing History:
Years Active: 2025
Title: J Andrew Duty: Innovator in Monoclonal Antibodies
Introduction
J Andrew Duty is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the development of monoclonal antibodies. His work focuses on addressing critical health issues related to the John Cunningham virus (JCV).
Latest Patents
J Andrew Duty holds a patent for "Monoclonal antibodies against JC virus." This patent includes monoclonal antibodies and antigen-binding fragments that specifically bind to the JCV. The patent also encompasses pharmaceutical compositions that utilize these antibodies, along with methods for their application in treating and preventing JCV infections and progressive multifocal leukoencephalopathy.
Career Highlights
Duty is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts research and develops innovative solutions in the medical field. His work has the potential to significantly impact the treatment of JCV-related conditions.
Collaborations
Some of his notable coworkers include Thomas Moran and Thomas Kraus, who contribute to the collaborative efforts in research and development at the Icahn School of Medicine.
Conclusion
J Andrew Duty's contributions to the field of monoclonal antibodies represent a significant advancement in medical science. His innovative work continues to pave the way for new treatments and therapies for JCV infections.
